BIOPACT RCT Compares Safety and Efficacy of Passeo-18 Lux to IN.PACT Admiral in the Treatment of Femoropopliteal Lesions
BIOTRONIK is proud to announce the completion of enrollment of the investigator-initiated BIOPACT randomized controlled trial (RCT). This non-inferiority study evaluates the safety and efficacy of paclitaxel drug-coated balloons (DCBs), comparing the BIOTRONIK Passeo®-18 Lux Paclitaxel releasing PTA balloon catheter to the Medtronic IN.PACT Admiral Paclitaxel-coated PTA balloon catheter.